Asahi Kasei Pharma Corp. v. Actelion Ltd. Verdict: When Business Development Deals Go Wrong

August 31, 2011
12:00 PM - 01:00 PM

Morgan Lewis and Merrill DataSite invite you to an engaging discussion on what can happen when business development deals go wrong, how to spot a potential breach of license, and what to do when litigation is imminent.

Morgan Lewis Litigation partners will share their experiences from a recently won licensing case with antitrust overtones. After a three-month trial, a California state court jury ordered Actelion Ltd. to pay Asahi Kasei Pharma Corp. $550 million in damages for interrupting an Asahi licensing agreement to develop hypertension drug Fasudil.

Rollin Chippey
Partner, Morgan Lewis

Christopher Banks
Partner, Morgan Lewis

Benjamin Smith
Partner, Morgan Lewis

David Yeary
Vice President, Merrill DataSite

August 31, 2011
12–1 pm ET | 9–10 am PT

For more information, contact Anita Van Keulen at anita.vankeulen@merrillcorp.com or 651.632.4281.